These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 325223)

  • 1. Point-mutation research: relevance for humans.
    Herbold BA; Röhrborn G; Buselmaier W
    J Toxicol Environ Health; 1977 May; 2(5):1183-91. PubMed ID: 325223
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay.
    Simmon VF; Rosenkranz HS; Zeiger E; Poirier LA
    J Natl Cancer Inst; 1979 Apr; 62(4):911-8. PubMed ID: 372659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of several classes of antitumor agents to Salmonella typhimurium TA98, TA100, and TA92.
    Seino Y; Nagao M; Yahagi T; Hoshi A; Kawachi T; Sugimura T
    Cancer Res; 1978 Jul; 38(7):2148-56. PubMed ID: 350383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of point mutations by different chemical mechanisms in the liver microsomal assay.
    Herbold B; Buselmaier W
    Mutat Res; 1976 Apr; 40(2):73-84. PubMed ID: 778610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic activity of isoniazid and hydrazine in mammalian test systems.
    Röhrborn G; Propping P; Buselmaier W
    Mutat Res; 1972 Oct; 16(2):189-94. PubMed ID: 4561497
    [No Abstract]   [Full Text] [Related]  

  • 6. Concentration-dependent mutation by alkylating agents in human lymphoblasts and Salmonella typhimurium: N-methyl-N-nitrosourethane and beta-propiolactone.
    Penman BW; Hoppe H; Thilly WG
    J Natl Cancer Inst; 1979 Oct; 63(4):903-7. PubMed ID: 384009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro.
    Levitt RC; Pelkonen O; Okey AB; Nebert DW
    J Natl Cancer Inst; 1979 Apr; 62(4):947-55. PubMed ID: 372661
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system.
    Rinkus SJ; Legator MS
    Cancer Res; 1979 Sep; 39(9):3289-318. PubMed ID: 383284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation of dimethylnitrosamine and diethyl-nitrosamine to mutagens.
    Malling HV; Frantz CN
    Mutat Res; 1974 Nov; 25(2):179-86. PubMed ID: 4279332
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutagenicity of N-nitrosodiethanolamine and its acetyl-derivatives [proceedings].
    Gilbert P; Rollmann B; Rondelet J; Mercier M; Poncelet F
    Arch Int Physiol Biochim; 1979 Oct; 87(4):813-4. PubMed ID: 93920
    [No Abstract]   [Full Text] [Related]  

  • 12. Relative sensitivities of forward and reverse mutation assays in Salmonella typhimurium.
    Skopek TR; Liber HL; Kaden DA; Thilly WG
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4465-9. PubMed ID: 360221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of carcinogens and related compounds tested for mutagenic activity.
    Poirier LA; Weisburger EK
    J Natl Cancer Inst; 1979 Apr; 62(4):833-40. PubMed ID: 372655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of promutagen activation by the antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
    McKee RH; Tometsko AM
    J Natl Cancer Inst; 1979 Aug; 63(2):473-7. PubMed ID: 287836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical review: will the Ames Salmonella assay system be used as a screen for presumptive carcinogens?
    Jacobs M
    J Environ Pathol Toxicol; 1979; 2(4):1205-15. PubMed ID: 376768
    [No Abstract]   [Full Text] [Related]  

  • 16. Collaborative studies on the Salmonella/microsome mutagenicity assay.
    Dunkel VC
    J Assoc Off Anal Chem; 1979 Jul; 62(4):874-82. PubMed ID: 387710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of cycasin aglycone (methylazoxymethanol), a naturally occurring carcinogen.
    Smith DW
    Science; 1966 May; 152(3726):1273-4. PubMed ID: 5327886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the mutagenic potency of chemical substances in a linear host-mediated assay. I. Experimental microbiological basis.
    Grafe A; Lorenz R; Vollmar J
    Mutat Res; 1975 Aug; 31(4):205-16. PubMed ID: 1095922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrazines as mutagens in a histidine-requiring auxotroph of Salmonella typhimurium.
    Tosk J; Schmeltz I; Hoffmann D
    Mutat Res; 1979 Mar; 66(3):247-52. PubMed ID: 375083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of tests for carcinogenicity.
    Purchase IF
    IARC Sci Publ; 1980; (27):343-9. PubMed ID: 7002781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.